The use of herbal and dietary supplements for COVID-19 prevention: a survey among the public in a Malaysian suburban town
Introduction: The spread of the novel coronavirus disease (COVID-19) may lead people to seek preventative measures. The use of herbal and dietary supplements (HDS) may have become prevalent during the COVID-19 pandemic. This study aims to identify the prevalence, predictors, and patterns of HDS us...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Elsevier
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/109183/ https://linkinghub.elsevier.com/retrieve/pii/S2210803323000283 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Introduction: The spread of the novel coronavirus disease (COVID-19) may lead people to seek preventative
measures. The use of herbal and dietary supplements (HDS) may have become prevalent during the COVID-19
pandemic. This study aims to identify the prevalence, predictors, and patterns of HDS use for COVID-19 prevention in a sample of the general public in a suburban town in Malaysia.
Methods: An online cross-sectional survey was conducted between May and June 2021 involving adults ≥ 18
years old. Data on the self-reported use of HDS for COVID-19 prevention were collected. Logistic regression
analysis was conducted to determine the predictors of HDS use.
Results: Overall, 41.9 % (168/401) reported using HDS to prevent COVID-19. Multivariate analysis showed that
HDS users were more likely to be individuals ≥ 40 years old (adjusted odds ratio [aOR] = 1.774, 95 % confidence
interval [CI] = 1.016 – 3.098), and to have had a history of HDS use prior to the pandemic (aOR = 19.378, 95 %
CI = 5.901 – 63.639). Most HDS users referred to social media or websites (66.7 %, 112/168) for HDS information. Approximately half of them had consulted either pharmacists or doctors about their HDS use.
Conclusion: HDS use to prevent COVID-19 was common among the respondents. Several issues - such as the
concurrent use of HDS with conventional medications, the use of unreliable sources of information, and the lack
of consultation with healthcare providers (HCPs) - indicate that HCPs should be more proactive in their
consultative and information-providing roles regarding HDS use. |
|---|